With a 6-4 vote, the group of independent advisers to the agency narrowly concluded that results from another clinical trial are needed to assess whether the therapy, called AMX0035, can help patients.
Two new studies of millions of people around the world suggest that doctors should be thinking more about cancer patients’ mental health, experts said.